News

Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...
A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
Are you tired of boring dieting and gruesome workouts? Then, medical weight loss treatment can be a solution for you. But ...
Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.
A study from the University of Gothenburg identifies specific brain neurons controlling semaglutide's weight loss effects.
Regeneron Pharmaceuticals, Inc. (REGN) on Monday said that it has entered into a strategic in-licensing agreement with ...
Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...
Legal battle over semaglutide between Novo Nordisk and Indian drugmakers will set precedent for future opportunities and ...
Researchers have found in a new cohort study that semaglutide offers significant protection against osteoporosis and gout in ...